# OnCo record paper-blueprint-phase-2-pd-l1-assays-jto-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-blueprint-phase-2-pd-l1-assays-jto-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-blueprint-phase-2-pd-l1-assays-jto-2018" ;
  schema:name "PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of Blueprint phase 2 project"@en ;
  schema:description "Five different stains for the same protein were run on 81 real lung cancer samples and read by pathologists from thirteen countries. Three of the five agree closely on tumour cells, one stains less and one stains more, and none of them can be read reliably on immune cells."@en ;
  schema:url <https://onco.cc/key-papers/paper-blueprint-phase-2-pd-l1-assays-jto-2018/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.jtho.2018.05.013>, <https://pubmed.ncbi.nlm.nih.gov/29800747/> ;
  schema:sameAs <https://doi.org/10.1016/j.jtho.2018.05.013> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Tsao MS, Kerr KM, Kockx M, et al." ;
  onco:related <https://onco.cc/biomarkers/pd-l1-tps/>, <https://onco.cc/biomarkers/pd-l1-tc-score/>, <https://onco.cc/biomarkers/pd-l1-ic-score/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:pathways <https://onco.cc/pathways/pd1-checkpoint/> ;
  onco:terms <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/biopsy/> ;
  onco:journals <https://onco.cc/journals/journal-of-thoracic-oncology/> .